US 6172061
Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative
expired A61KA61K31/335A61K31/351
Quick answer
US patent 6172061 (Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative) held by Takeda Chemical Industries Ltd. expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Takeda Chemical Industries Ltd.
- Grant date
- Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/335, A61K31/351, A61K31/452, A61K31/4523